CoreAge Rx vs Ascend Medical
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Ascend Medical head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 60 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Ascend Medical a bad call — it's best for people comparing clinician-led care and included coaching who can confirm their starting supply, later vial quote and visit coverage. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Ascend Medical |
|---|---|---|
| Brief Score | 94/100 (A) | 60/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $225 starting package; full quote unconfirmed First-eight-week program described, then pay-per-refill. Exact preparation, supplied quantity and subsequent vial charge need confirmation; clinical copays/self-pay visits are separate. Coaching included; therapy optional. Appointment changes need 24 business hours notice or potential $49 Family Medicine/$99 Behavioral Health fee. Medication refund terms unconfirmed. Full price detailsSemaglutide prescription and complete selected-medication quote unknown; starting package $225 advertised, first-eight-week program described; preparation and full supplied quantity unconfirmed, provider visits billed separately through insurance or self-pay |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $240 starting package; full quote unconfirmed First-eight-week program described, then pay-per-refill. Exact preparation, supplied quantity and subsequent vial charge need confirmation; clinical copays/self-pay visits are separate. Coaching included; therapy optional. Appointment changes need 24 business hours notice or potential $49 Family Medicine/$99 Behavioral Health fee. Medication refund terms unconfirmed. Full price detailsTirzepatide prescription and complete selected-medication quote unknown; starting package $240 advertised, first-eight-week program described; preparation and full supplied quantity unconfirmed, provider visits billed separately through insurance or self-pay |
| Coverage | US only; restrictions by state, confirmed at intake | Georgia clinic locations and virtual care advertised; confirm the clinician can provide weight treatment in the patient state |
| Brand-name access | Not confirmed | Named active ingredients do not establish which branded or compounded preparation the package supplies. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Ascend Medical: Starting packages: semaglutide $225, tirzepatide $240; selected preparation/supply unconfirmed. After the initial eight weeks, pay-per-refill; clinician copays separate. Appointment changes need 24 business hours to avoid $49/$99 fees.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.